Patent · US Active

Kit for diagnosing malignant melanoma

US9465030B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignees

National Cancer Center · JP
LSIP, LLC · JP

Inventors

Tetsuya Nakatsura · Chiba, JP
Keigo Saito · Chiba, JP

Key dates

Filing date	Jun 17, 2013
Grant date	Oct 11, 2016
Priority date	—
Expiry date	Jun 17, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4727
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided is a kit for diagnosing at a high reproducibility, said kit being produced by preparing a monoclonal antibody against GPC3 and a monoclonal antibody against SPARC that are superior in quality stability to commercially available and commonly employed antibodies, and using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.